Resistance in Enterobacterales Is Higher Among People Living With Human Immunodeficiency Virus

被引:9
作者
Henderson, Heather, I [1 ,2 ]
Napravnik, Sonia [1 ,2 ]
Gower, Emily W. [1 ]
Aiello, Allison E. [1 ]
Kinlaw, Alan C. [3 ,4 ]
Williams, Billy [5 ]
Wohl, David A. [2 ]
van Duin, David [2 ]
机构
[1] Univ N Carolina, Dept Epidemiol, 135 Dauer Dr,2101 McGavran Greenberg Hall,CB 743, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC USA
[3] Univ N Carolina, Sch Pharm, Div Pharmaceut Outcomes & Policy, Chapel Hill, NC USA
[4] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA
[5] Univ North Carolina Hosp, Clin Microbiol Lab, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
antimicrobial-resistant Enterobacterales; HIV; epidemiology; KLEBSIELLA-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; BACTERIAL-RESISTANCE; RISK-FACTORS; CARE CENTER; INFECTIONS; OUTCOMES; SURVEILLANCE; INDIVIDUALS; DISEASE;
D O I
10.1093/cid/ciab901
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Multidrug-resistant Enterobacterales (MDR-E) are important pathogens. People living with human immunodeficiency virus (HIV; PLWH) may be at greater risk for MDR-E infection given relatively high antibiotic exposure and burden of comorbidities. Methods We analyzed data from 36 521 patients in a healthcare system in North Carolina who had a clinical culture with growth of an Enterobacterales species from 2000 to 2018; 440 were PLWH. We used generalized linear models to estimate prevalence ratios and differences, contrasting PLWH and people not living with HIV (PNLWH) for resistance to individual antibiotic classes, as well as MDR-E. We assessed trends in prevalence over time by calculating the 5-year moving average and fitting restricted cubic spline models. Results The overall prevalence of MDR-E was higher among PLWH (21.5%; 95% confidence interval [CI], 18.2%-25.1%) vs PNLWH (16.5%; 95% CI, 16.2%-16.9%), with an adjusted prevalence ratio of 1.38 (95% CI, 1.14-1.65). PLWH had higher rates of antimicrobial resistance than PNLWH for all antibiotic classes analyzed, including penicillins, penicillin/beta lactamase inhibitor combinations, and sulfonamides. MDR-E prevalence was 3 to 10 percentage points higher among PLWH than PNLWH throughout the study period based on the 5-year moving average. Conclusions In a large clinical study population in the southeastern United States from 2000 to 2018, the prevalence of antibacterial resistance among Enterobacterales was consistently higher among PLWH than PNLWH. These data highlight the importance of identifying and mitigating the factors that contribute to antimicrobial resistance in PLWH, given the potential clinical consequences of these resistant pathogens. In a large health system in North Carolina from 2000 to 2018, people living with human immunodeficiency virus (HIV) had a consistently higher prevalence of antimicrobial-resistant, including multidrug-resistant, Enterobacterales isolates than did people not living with HIV.
引用
收藏
页码:28 / 34
页数:7
相关论文
共 39 条
[1]  
Aberg Judith A, 2012, Top Antivir Med, V20, P101
[2]  
[Anonymous], 2018, M100ED30 PERF STAND
[3]  
Bandera A, 2018, CURR OPIN HIV AIDS, V13, P73, DOI [10.1097/COH.0000000000000429, 10.1097/coh.0000000000000429]
[4]   A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients [J].
Ben-Ami, Ronen ;
Rodriguez-Bano, Jesus ;
Arslan, Hande ;
Pitout, Johann D. D. ;
Quentin, Claudine ;
Calbo, Esther S. ;
Azap, Oezlem K. ;
Arpin, Corinne ;
Pascual, Alvaro ;
Livermore, David M. ;
Garau, Javier ;
Carmeli, Yehuda .
CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) :682-690
[5]  
Egwuatu C C, 2016, Afr J Infect Dis, V10, P156, DOI 10.21010/ajid.v10i2.12
[6]   Risk Factors and Clinical Impact of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae [J].
Gasink, Leanne B. ;
Edelstein, Paul H. ;
Lautenbach, Ebbing ;
Synnestvedt, Marie ;
Fishman, Neil O. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (12) :1180-1185
[7]   Causes of Death in HIV-1-Infected Patients Treated with Antiretroviral Therapy, 1996-2006: Collaborative Analysis of 13 HIV Cohort Studies [J].
Gill, John ;
May, Margaret ;
Lewden, Charlotte ;
Saag, Mike ;
Mugavero, Michael ;
Reiss, Peter ;
Ledergerber, Bruno ;
Mocroft, Amanda ;
Harris, Ross ;
Fux, Christoph A. ;
Justice, Amy ;
Costagliola, Dominique ;
Casabona, Jordi ;
Hogg, Robert S. ;
Khaykin, Pavel ;
Lampe, Fiona ;
Vehreschild, Janne ;
Sterne, Jonathan A. C. ;
Egger, Matthias ;
Brodt, Hans-Reinhard ;
Casabona, Jordi ;
Chene, Genevieve ;
Costagliola, Dominique ;
Dabis, Francois ;
Monforte, Antonella D'Arminio ;
de Wolf, Frank ;
Faetkenheuer, Gerd ;
Gill, John ;
Guest, Jodie ;
Hogg, Robert S. ;
Justice, Amy ;
Kirk, Ole ;
Kitahata, Mari ;
Lampe, Fiona ;
Ledergerber, Bruno ;
Reiss, Peter ;
Sterling, Tim .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (10) :1387-1396
[8]   Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population [J].
Guaraldi, Giovanni ;
Orlando, Gabriella ;
Zona, Stefano ;
Menozzi, Marianna ;
Carli, Federica ;
Garlassi, Elisa ;
Berti, Alessandra ;
Rossi, Elisa ;
Roverato, Alberto ;
Palella, Frank .
CLINICAL INFECTIOUS DISEASES, 2011, 53 (11) :1120-1126
[9]  
Huizen J., 2019, WORLD BIGGEST PHARM
[10]   Aging with HIV in the ART era [J].
Kaplan-Lewis, Emma ;
Aberg, Judith A. ;
Lee, Mikyung .
SEMINARS IN DIAGNOSTIC PATHOLOGY, 2017, 34 (04) :384-397